POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <30 mL/min/1.73m2: FINDINGS FROM THE DAPA-CKD TRIAL

oleh: G.M. Chertow, P. Vart, N. Jongs, R.D. Toto, J.L. Gorriz, F.F. Hou, J.J.V. McMurray, R. Correa-Rotter, P. Rossing, C.D. Sjöström, B.V. Stefánsson, A.M. Langkilde, D.C. Wheeler, H. Lambers Heerspink